<DOC>
	<DOCNO>NCT00265304</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety IDEA-033 ( anti-inflammatory pain-relieving drug apply skin ) comparison naproxen ( anti-inflammatory pain-relieving drug take mouth ) treatment osteoarthritis knee .</brief_summary>
	<brief_title>A Long-Term Safety Study IDEA-033 Comparison Oral Naproxen Treatment Osteoarthritis Knee</brief_title>
	<detailed_description>This double-blind , active-controlled study safety IDEA-033 comparison oral naproxen treatment sign symptom osteoarthritis knee patient complete Study 17-007 discontinue Study 17-007 due lack efficacy . If sufficient number patient enroll Study 17-007 , patient osteoarthritis knee enrol Study 17-007 may enrol study . Patients treat IDEA-033 Study 17-007 receive 100 mg per knee ketoprofen gel twice daily one placebo capsule twice daily 52 week . Patients treat oral naproxen placebo Study 17-007 receive 500 mg naproxen over-encapsulated tablet twice daily placebo topical gel twice daily 52 week . Patients participate Study 17-007 randomize receive one two treatment . The primary outcome study include incidence severity adverse event , dermal-irritation score , change routine clinical laboratory test vital sign obtain visit . Patients assign IDEA-033 Study 17-007 topically apply 100 mg per knee ketoprofen gel twice daily take one oral placebo capsule twice daily 52 week . Patients assign oral naproxen placebo Study 17-007 take one 500 mg naproxen over-encapsulated tablet orally twice daily apply placebo topical gel twice daily 52 week . Patients participate Study 17-007 randomize receive one two treatment .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Patients complete Study 17007 discontinue Study 17007 due lack efficacy Patients complete discontinue Study 17007 must osteoarthritis knee minimum six month Have moderate pain involve knee take nonsteroidal antiinflammatory drug ( NSAIDs ) Must use oral NSAID least three day per week last three month , 25 30 day screen Demonstrate xray evidence osteoarthritis involve knee last six month Any patient currently receive physical therapy either knee history allergy , hypersensitivity contraindication ketoprofen , naproxen , acetaminophen , NSAID idiosyncrasy , medical condition would compromise ability subject complete require assessment visit For patient participate Study 17007 : Grade 1 Grade 4 severity involve knee base xray criterion Received intraarticular injection arthroscopy involve knee three month screen visit Have large bulge effusion , inflammation involve knee could relate gout , pseudogoutinduced synovitis , infection Have history partial total knee replacement either knee , history gout , pseudogout induce synovitis , infection severe knee</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Osteoarthritis</keyword>
</DOC>